Ontology type: schema:ScholarlyArticle
2018-07
AUTHORSJohn Hilton, Lisa Vandermeer, Marta Sienkiewicz, Sasha Mazzarello, Brian Hutton, Carol Stober, Dean Fergusson, Phillip Blanchette, Anil A. Joy, A. Brianne Bota, Mark Clemons
ABSTRACTPURPOSE: Despite its widespread use as primary febrile neutropenia (FN) prophylaxis during chemotherapy for early-stage breast cancer, the optimal duration of daily filgrastim is unknown. Using the minimum effective duration may improve patient comfort and acceptability while reducing costs. Yet, suboptimal dosing may also negatively impact patient care. A survey was performed to obtain information regarding current practices for granulocyte colony-stimulating factor (G-CSF) use. METHODS: Canadian oncologists involved in the treatment of breast cancer patients, as well as patients who had received neo/adjuvant chemotherapy for breast cancer, were surveyed. Standardized surveys were designed to collect information on perceived reasons for G-CSF use and current practices. RESULTS: The surveys were completed by 38/50 (76%) physicians and 95/97 (98%) patients. For physicians, there was variability in the choice of chemotherapy regimens that required G-CSF support, the dose of filgrastim prescribed and the number of days prescribed. The majority of physicians reported using 5 (31.6%), 7 (47.4%), or 10 (13.2%) days of therapy. Nearly half of the patients (46.3%) recalled having experienced at least one of the chemotherapy-related complications including chemotherapy delays, dose reductions, and FN. While on filgrastim, 66.3% of patients reported myalgia and bone pain. Both physicians and patients expressed interest in participating in clinical trials designed to optimize the duration of filgrastim administration. CONCLUSIONS: Significant variability in practice exists with respect to filgrastim administration. Definitive studies are therefore required to standardize and improve care, as this has the potential to impact treatment outcomes, patient quality of life, and cost savings. More... »
PAGES2323-2331
http://scigraph.springernature.com/pub.10.1007/s00520-018-4074-8
DOIhttp://dx.doi.org/10.1007/s00520-018-4074-8
DIMENSIONShttps://app.dimensions.ai/details/publication/pub.1100827000
PUBMEDhttps://www.ncbi.nlm.nih.gov/pubmed/29411131
JSON-LD is the canonical representation for SciGraph data.
TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT
[
{
"@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json",
"about": [
{
"id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112",
"inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/",
"name": "Oncology and Carcinogenesis",
"type": "DefinedTerm"
},
{
"id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11",
"inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/",
"name": "Medical and Health Sciences",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Adult",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Aged",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Breast Neoplasms",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Female",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Filgrastim",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Hematologic Agents",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Humans",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Middle Aged",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Neoplasm Staging",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Patients",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Physicians",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Surveys and Questionnaires",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Treatment Outcome",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Young Adult",
"type": "DefinedTerm"
}
],
"author": [
{
"affiliation": {
"alternateName": "Ottawa Hospital",
"id": "https://www.grid.ac/institutes/grid.412687.e",
"name": [
"Department of Medicine, Division of Medical Oncology, The Ottawa Hospital and University of Ottawa, Ottawa, Canada",
"Ottawa Hospital Research Institute and University of Ottawa, Ottawa, Canada",
"Division of Medical Oncology, The Ottawa Hospital Cancer Centre, 501 Smyth Road, Ottawa, Canada"
],
"type": "Organization"
},
"familyName": "Hilton",
"givenName": "John",
"id": "sg:person.01011642231.93",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01011642231.93"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Ottawa Hospital",
"id": "https://www.grid.ac/institutes/grid.412687.e",
"name": [
"Ottawa Hospital Research Institute and University of Ottawa, Ottawa, Canada"
],
"type": "Organization"
},
"familyName": "Vandermeer",
"givenName": "Lisa",
"id": "sg:person.0761055556.65",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0761055556.65"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Ottawa Hospital",
"id": "https://www.grid.ac/institutes/grid.412687.e",
"name": [
"Ottawa Hospital Research Institute and University of Ottawa, Ottawa, Canada"
],
"type": "Organization"
},
"familyName": "Sienkiewicz",
"givenName": "Marta",
"id": "sg:person.013516710304.84",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013516710304.84"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Ottawa Hospital",
"id": "https://www.grid.ac/institutes/grid.412687.e",
"name": [
"Ottawa Hospital Research Institute and University of Ottawa, Ottawa, Canada"
],
"type": "Organization"
},
"familyName": "Mazzarello",
"givenName": "Sasha",
"id": "sg:person.0737376756.24",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0737376756.24"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Ottawa Hospital",
"id": "https://www.grid.ac/institutes/grid.412687.e",
"name": [
"Ottawa Hospital Research Institute and University of Ottawa, Ottawa, Canada",
"Clinical Epidemiology Program, The Ottawa Hospital Research Institute, Ottawa, Canada"
],
"type": "Organization"
},
"familyName": "Hutton",
"givenName": "Brian",
"id": "sg:person.01235465321.38",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01235465321.38"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Ottawa Hospital",
"id": "https://www.grid.ac/institutes/grid.412687.e",
"name": [
"Ottawa Hospital Research Institute and University of Ottawa, Ottawa, Canada"
],
"type": "Organization"
},
"familyName": "Stober",
"givenName": "Carol",
"id": "sg:person.012546702415.53",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012546702415.53"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Ottawa Hospital",
"id": "https://www.grid.ac/institutes/grid.412687.e",
"name": [
"Ottawa Hospital Research Institute and University of Ottawa, Ottawa, Canada",
"Clinical Epidemiology Program, The Ottawa Hospital Research Institute, Ottawa, Canada"
],
"type": "Organization"
},
"familyName": "Fergusson",
"givenName": "Dean",
"id": "sg:person.01152765352.19",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01152765352.19"
],
"type": "Person"
},
{
"affiliation": {
"name": [
"Department of Oncology, Division of Medical Oncology, London Regional Cancer Program, University of Western Ontario, London, Canada"
],
"type": "Organization"
},
"familyName": "Blanchette",
"givenName": "Phillip",
"id": "sg:person.01157236466.66",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01157236466.66"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "University of Alberta",
"id": "https://www.grid.ac/institutes/grid.17089.37",
"name": [
"Department of Oncology, Division of Medical Oncology, Cross Cancer Institute, University of Alberta, Edmonton, Canada"
],
"type": "Organization"
},
"familyName": "Joy",
"givenName": "Anil A.",
"id": "sg:person.01131333657.06",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01131333657.06"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Ottawa Hospital",
"id": "https://www.grid.ac/institutes/grid.412687.e",
"name": [
"Ottawa Hospital Research Institute and University of Ottawa, Ottawa, Canada"
],
"type": "Organization"
},
"familyName": "Brianne Bota",
"givenName": "A.",
"id": "sg:person.011374502104.85",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011374502104.85"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Ottawa Hospital",
"id": "https://www.grid.ac/institutes/grid.412687.e",
"name": [
"Department of Medicine, Division of Medical Oncology, The Ottawa Hospital and University of Ottawa, Ottawa, Canada",
"Ottawa Hospital Research Institute and University of Ottawa, Ottawa, Canada"
],
"type": "Organization"
},
"familyName": "Clemons",
"givenName": "Mark",
"id": "sg:person.01216107435.90",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01216107435.90"
],
"type": "Person"
}
],
"citation": [
{
"id": "https://doi.org/10.1111/jep.12379",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1004328454"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1007/s00520-015-2941-0",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1009295769",
"https://doi.org/10.1007/s00520-015-2941-0"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1016/j.clgc.2016.07.018",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1019956213"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1200/jco.2006.06.5391",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1020781072"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1200/jco.2015.62.3488",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1021783900"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1007/s10549-016-4028-0",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1023282724",
"https://doi.org/10.1007/s10549-016-4028-0"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1007/s10549-016-4028-0",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1023282724",
"https://doi.org/10.1007/s10549-016-4028-0"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1016/j.ejca.2010.10.013",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1034049872"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1093/annonc/mdq196",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1034733668"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1093/annonc/mdq196",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1034733668"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1002/14651858.cd007913.pub2",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1036547737"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1200/jco.2006.06.4451",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1042630049"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.3747/co.19.948",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1046103284"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1007/s00520-015-2731-8",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1052193278",
"https://doi.org/10.1007/s00520-015-2731-8"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1007/s00520-017-3580-4",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1074228344",
"https://doi.org/10.1007/s00520-017-3580-4"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1007/s00520-017-3580-4",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1074228344",
"https://doi.org/10.1007/s00520-017-3580-4"
],
"type": "CreativeWork"
}
],
"datePublished": "2018-07",
"datePublishedReg": "2018-07-01",
"description": "PURPOSE: Despite its widespread use as primary febrile neutropenia (FN) prophylaxis during chemotherapy for early-stage breast cancer, the optimal duration of daily filgrastim is unknown. Using the minimum effective duration may improve patient comfort and acceptability while reducing costs. Yet, suboptimal dosing may also negatively impact patient care. A survey was performed to obtain information regarding current practices for granulocyte colony-stimulating factor (G-CSF) use.\nMETHODS: Canadian oncologists involved in the treatment of breast cancer patients, as well as patients who had received neo/adjuvant chemotherapy for breast cancer, were surveyed. Standardized surveys were designed to collect information on perceived reasons for G-CSF use and current practices.\nRESULTS: The surveys were completed by 38/50 (76%) physicians and 95/97 (98%) patients. For physicians, there was variability in the choice of chemotherapy regimens that required G-CSF support, the dose of filgrastim prescribed and the number of days prescribed. The majority of physicians reported using 5 (31.6%), 7 (47.4%), or 10 (13.2%) days of therapy. Nearly half of the patients (46.3%) recalled having experienced at least one of the chemotherapy-related complications including chemotherapy delays, dose reductions, and FN. While on filgrastim, 66.3% of patients reported myalgia and bone pain. Both physicians and patients expressed interest in participating in clinical trials designed to optimize the duration of filgrastim administration.\nCONCLUSIONS: Significant variability in practice exists with respect to filgrastim administration. Definitive studies are therefore required to standardize and improve care, as this has the potential to impact treatment outcomes, patient quality of life, and cost savings.",
"genre": "research_article",
"id": "sg:pub.10.1007/s00520-018-4074-8",
"inLanguage": [
"en"
],
"isAccessibleForFree": false,
"isPartOf": [
{
"id": "sg:journal.1103473",
"issn": [
"0941-4355",
"1433-7339"
],
"name": "Supportive Care in Cancer",
"type": "Periodical"
},
{
"issueNumber": "7",
"type": "PublicationIssue"
},
{
"type": "PublicationVolume",
"volumeNumber": "26"
}
],
"name": "Filgrastim use in patients receiving chemotherapy for early-stage breast cancer\u2014a survey of physicians and patients",
"pagination": "2323-2331",
"productId": [
{
"name": "readcube_id",
"type": "PropertyValue",
"value": [
"07ec8e1e450095da4cb0a62cb82fad2132247c8ae9ccc129a32a3df32d2c0a05"
]
},
{
"name": "pubmed_id",
"type": "PropertyValue",
"value": [
"29411131"
]
},
{
"name": "nlm_unique_id",
"type": "PropertyValue",
"value": [
"9302957"
]
},
{
"name": "doi",
"type": "PropertyValue",
"value": [
"10.1007/s00520-018-4074-8"
]
},
{
"name": "dimensions_id",
"type": "PropertyValue",
"value": [
"pub.1100827000"
]
}
],
"sameAs": [
"https://doi.org/10.1007/s00520-018-4074-8",
"https://app.dimensions.ai/details/publication/pub.1100827000"
],
"sdDataset": "articles",
"sdDatePublished": "2019-04-11T09:34",
"sdLicense": "https://scigraph.springernature.com/explorer/license/",
"sdPublisher": {
"name": "Springer Nature - SN SciGraph project",
"type": "Organization"
},
"sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000346_0000000346/records_99815_00000004.jsonl",
"type": "ScholarlyArticle",
"url": "https://link.springer.com/10.1007%2Fs00520-018-4074-8"
}
]Download the RDF metadata as: json-ld nt turtle xml License info
JSON-LD is a popular format for linked data which is fully compatible with JSON.
curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s00520-018-4074-8'
N-Triples is a line-based linked data format ideal for batch operations.
curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s00520-018-4074-8'
Turtle is a human-readable linked data format.
curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s00520-018-4074-8'
RDF/XML is a standard XML format for linked data.
curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s00520-018-4074-8'
This table displays all metadata directly associated to this object as RDF triples.
246 TRIPLES
21 PREDICATES
56 URIs
35 LITERALS
23 BLANK NODES